BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol. 2003;129:727-734. [PMID: 14557879 DOI: 10.1007/s00432-003-0499-6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Rieder G, Tessier AJ, Qiao XT, Madison B, Gumucio DL, Merchant JL. Helicobacter-induced intestinal metaplasia in the stomach correlates with Elk-1 and serum response factor induction of villin. J Biol Chem 2005;280:4906-12. [PMID: 15576363 DOI: 10.1074/jbc.M413399200] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 Oue N, Sentani K, Noguchi T, Ohara S, Sakamoto N, Hayashi T, Anami K, Motoshita J, Ito M, Tanaka S. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer. 2009;125:2383-2392. [PMID: 19670418 DOI: 10.1002/ijc.24624] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
3 Ha Kim G, Am Song G, Youn Park D, Han Lee S, Hyun Lee D, Oh Kim T, Jae Jo H, Heo J, Hwan Kang D, Cho M. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype. Scand J Gastroenterol. 2006;41:880-886. [PMID: 16803685 DOI: 10.1080/00365520500497140] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
4 Tatematsu M, Tsukamoto T, Mizoshita T. History of Gastric Carcinoma Research in Japan: Basic Aspects. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 3-28. [DOI: 10.1007/4-431-27713-7_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Oue N, Sentani K, Sakamoto N, Motoshita J, Nishisaka T, Fukuhara T, Matsuura H, Sasaki H, Nakachi K, Yasui W. Characteristic gene expression in stromal cells of gastric cancers among atomic-bomb survivors. Int J Cancer 2009;124:1112-21. [PMID: 19058179 DOI: 10.1002/ijc.24060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
6 Katano T, Ootani A, Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Kataoka H, Joh T. Gastric Mesenchymal Myofibroblasts Maintain Stem Cell Activity and Proliferation of Murine Gastric Epithelium in Vitro. The American Journal of Pathology 2015;185:798-807. [DOI: 10.1016/j.ajpath.2014.11.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
7 Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11:2959-2964. [PMID: 27123046 DOI: 10.3892/ol.2016.4337] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
8 Shiratsu K, Higuchi K, Nakayama J. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach. Cancer Sci. 2014;105:126-133. [PMID: 24138592 DOI: 10.1111/cas.12305] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
9 Mizoshita T, Tsukamoto T, Tanaka H, Takenaka Y, Kato S, Cao X, Joh T, Tatematsu M. Colonic and small-intestinal phenotypes in gastric cancers: Relationships with clinicopathological findings. Pathol Int 2005;55:611-8. [DOI: 10.1111/j.1440-1827.2005.01878.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
10 Mori Y, Kataoka H, Miura Y, Kawaguchi M, Kubota E, Ogasawara N, Oshima T, Tanida S, Sasaki M, Ohara H, Mizoshita T, Tatematsu M, Asai K, Joh T. Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. Int J Cancer 2007;121:241-7. [PMID: 17330845 DOI: 10.1002/ijc.22654] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
11 Inada K, Mizoshita T, Tsukamoto T, Porter EM, Tatematsu M. Paneth type gastric cancer cells exhibit expression of human defensin-5. Histopathology 2005;47:330-1. [DOI: 10.1111/j.1365-2559.2005.02113.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 de Paiva Haddad LB, Patzina RA, Penteado S, Montagnini AL, da Cunha JE, Machado MC, Jukemura J. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. J Gastrointest Surg. 2010;14:719-728. [PMID: 20107918 DOI: 10.1007/s11605-010-1156-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
13 Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004;54:392-400. [PMID: 15144397 DOI: 10.1111/j.1440-1827.2004.01647.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
14 Park do Y, Srivastava A, Kim GH, Mino-Kenudson M, Deshpande V, Zukerberg LR, Song GA, Lauwers GY. CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance. Mod Pathol. 2010;23:54-61. [PMID: 19820687 DOI: 10.1038/modpathol.2009.135] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
15 Wang XT, Wei WY, Kong FB, Lian C, Luo W, Xiao Q, Xie YB. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures. J Exp Clin Cancer Res. 2012;31:98. [PMID: 23181722 DOI: 10.1186/1756-9966-31-98] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
16 Mizoshita T, Kataoka H, Kubota E, Shimura T, Mori Y, Wada T, Ogasawara N, Sasaki M, Kamiya T, Sakamoto M, Akamo Y, Joh T. AN ENDOCRINE CELL CARCINOMA WITH GASTRIC-AND-INTESTINAL MIXED PHENOTYPE ADENOCARCINOMA COMPONENT IN THE STOMACH. Digestive Endoscopy 2009;21:258-61. [DOI: 10.1111/j.1443-1661.2009.00903.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther. 2006;24 Suppl 4:71-80. [PMID: 17209848 DOI: 10.1111/j.1365-2036.2006.00028.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
18 Chen G, Jiao ZY. Challenge and thought on treatment of diffuse gastric cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(17): 2608-2616 [DOI: 10.11569/wcjd.v24.i17.2608] [Reference Citation Analysis]
19 Satake S, Semba S, Matsuda Y, Usami Y, Chiba H, Sawada N, Kasuga M, Yokozaki H. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma. Pathol Int. 2008;58:156-163. [PMID: 18251778 DOI: 10.1111/j.1440-1827.2007.02204.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
20 Otsuka T, Tsukamoto T, Mizoshita T, Inada K, Takenaka Y, Kato S, Yamamura Y, Miki K, Tatematsu M. Coexistence of gastric- and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach. Pathol Int 2005;55:170-9. [PMID: 15826243 DOI: 10.1111/j.1440-1827.2005.01809.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
21 Qin R, Wang NN, Chu J, Wang X. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions. World J Gastroenterol 2012; 18(25): 3296-3302 [PMID: 22783055 DOI: 10.3748/wjg.v18.i25.3296] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
22 Oz Puyan F, Can N, Ozyilmaz F, Usta U, Sut N, Tastekin E, Altaner S. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters. J Cancer Res Clin Oncol. 2011;137:1749-1762. [PMID: 21909647 DOI: 10.1007/s00432-011-1044-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
23 Saad RS, Ghorab Z, Khalifa MA, Xu M. CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg 2011; 3(11): 159-166 [PMID: 22180832 DOI: 10.4240/wjgs.v3.i11.159] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
24 Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K, Takano Y. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol. 2006;132:817-823. [PMID: 16807756 DOI: 10.1007/s00432-006-0135-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
25 Sentani K, Matsuda M, Oue N, Uraoka N, Naito Y, Sakamoto N, Yasui W. Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma. Gastric Cancer 2014;17:412-22. [PMID: 24048760 DOI: 10.1007/s10120-013-0302-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
26 Xiao W, Hong H, Awadallah A, Zhou L, Xin W. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis. PLoS One 2014;9:e86853. [PMID: 24489794 DOI: 10.1371/journal.pone.0086853] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kim HS, Lee JS, Freund JN, Min KW, Lee JS, Kim W, Juhng SW, Park CS. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. J Gastroenterol Hepatol. 2006;21:438-442. [PMID: 16509871 DOI: 10.1111/j.1440-1746.2005.03933.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
28 Ge J, Chen Z, Wu S, Yuan W, Hu B, Chen Z. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. Clin Oncol (R Coll Radiol). 2008;20:275-283. [PMID: 18353622 DOI: 10.1016/j.clon.2008.01.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
29 Dang LH, Chen F, Knock SA, Huang EH, Feng J, Appelman HD, Dang DT. CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45. Oncogene. 2006;25:2048-2059. [PMID: 16331267 DOI: 10.1038/sj.onc.1209243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
30 Anami K, Oue N, Noguchi T, Sakamoto N, Sentani K, Hayashi T, Hinoi T, Okajima M, Graff JM, Yasui W. Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype. J Pathol 2010;221:275-84. [DOI: 10.1002/path.2717] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
31 Kim GH, Song GA, Park DY, Lee DH, Kim TO, Lee SH, Heo J, Kang DH, Cho M. Clinicopathologic significance of gastric and intestinal phenotypic marker expression in gastric carcinomas. Korean J Intern Med 2005;20:191-7. [PMID: 16295776 DOI: 10.3904/kjim.2005.20.3.191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Zhang XX, Yu RL, Dai XS, Xie Q. Prognostic significance of expression of MCM7 and CDX2 in stage Ⅱ colorectal cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(3): 495-501 [DOI: 10.11569/wcjd.v23.i3.495] [Reference Citation Analysis]
33 Yamamichi N, Inada K, Furukawa C, Sakurai K, Tando T, Ishizaka A, Haraguchi T, Mizutani T, Fujishiro M, Shimomura R, Oka M, Ichinose M, Tsutsumi Y, Omata M, Iba H. Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells. Exp Cell Res 2009;315:1779-89. [PMID: 19371634 DOI: 10.1016/j.yexcr.2009.01.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
34 Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Ebi M, Mori Y, Kataoka H, Kamiya T, Joh T. Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN Gastroenterol 2013;2013:304894. [PMID: 23691335 DOI: 10.1155/2013/304894] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
35 Goldstein NS, Bosler DS. Immunohistochemistry of the Gastrointestinal Tract, Pancreas, Bile Ducts, Gallbladder and Liver. Diagnostic Immunohistochemistry. Elsevier; 2006. pp. 442-508. [DOI: 10.1016/b978-0-443-06652-8.50019-3] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
36 Li CM, Gocheva V, Oudin MJ, Bhutkar A, Wang SY, Date SR, Ng SR, Whittaker CA, Bronson RT, Snyder EL, Gertler FB, Jacks T. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis. Genes Dev 2015;29:1850-62. [PMID: 26341558 DOI: 10.1101/gad.267393.115] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
37 Hirata Y, Ogasawara N, Sasaki M, Mizushima T, Shimura T, Mizoshita T, Mori Y, Kubota E, Wada T, Tanida S, Kataoka H, Kamiya T, Higashiyama S, Joh T. BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers. Br J Cancer 2009;100:1320-9. [PMID: 19337254 DOI: 10.1038/sj.bjc.6605010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
38 Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol. 2005;207:185-198. [PMID: 16086444 DOI: 10.1002/path.1827] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 5.2] [Reference Citation Analysis]
39 Aoki K, Aoki M, Sugai M, Harada N, Miyoshi H, Tsukamoto T, Mizoshita T, Tatematsu M, Seno H, Chiba T, Oshima M, Hsieh CL, Taketo MM. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Oncogene 2007;26:3511-20. [PMID: 17160019 DOI: 10.1038/sj.onc.1210141] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
40 Mizoshita T, Tsukamoto T, Cao X, Otsuka T, Ito S, Takahashi E, Nakamura S, Nakamura T, Yamamura Y, Tatematsu M. Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype. Gastric Cancer. 2005;8:164-172. [PMID: 16086119 DOI: 10.1007/s10120-005-0331-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
41 Tsukamoto H, Mizoshita T, Katano T, Hayashi N, Ozeki K, Ebi M, Shimura T, Mori Y, Tanida S, Kataoka H, Tsukamoto T, Tatematsu M, Joh T. Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Exp Toxicol Pathol 2015;67:271-7. [PMID: 25617151 DOI: 10.1016/j.etp.2015.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
42 Tatematsu M, Tsukamoto T, Mizoshita T. Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter. 2005;10:97-106. [PMID: 15810939 DOI: 10.1111/j.1523-5378.2005.00305.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
43 Katano T, Ootani A, Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Ebi M, Mori Y, Kataoka H, Kamiya T. Establishment of a long-term three-dimensional primary culture of mouse glandular stomach epithelial cells within the stem cell niche. Biochem Biophys Res Commun. 2013;432:558-563. [PMID: 23485463 DOI: 10.1016/j.bbrc.2013.02.051] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
44 Song K, Yang Q, Yan Y, Yu X, Xu K, Xu J. Gastric mucin phenotype indicates aggressive biological behaviour in early differentiated gastric adenocarcinomas following endoscopic treatment. Diagn Pathol 2021;16:62. [PMID: 34256780 DOI: 10.1186/s13000-021-01122-2] [Reference Citation Analysis]
45 Wu XS, Akiyama Y, Igari T, Kawamura T, Hiranuma S, Shibata T, Tsuruta K, Koike M, Arii S, Yuasa Y. Expression of homeodomain protein CDX2 in gallbladder carcinomas. J Cancer Res Clin Oncol. 2005;131:271-278. [PMID: 15645288 DOI: 10.1007/s00432-004-0658-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
46 Yagi K, Nagayama I, Hoshi T, Abe S, Morita SI, Suda T, Hasegawa G, Sato YI, Terai S. Green epithelium revealed by narrow-band imaging (NBI): a feature for practical assessment of extent of gastric cancer after H. pylori eradication. Endosc Int Open 2018;6:E1289-95. [PMID: 30410947 DOI: 10.1055/a-0746-3449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Zhou Q, Zhang H, Jiang X, Du A. The gene structure and promoter region of the vaccine target aminopeptidase H11 from the blood-sucking nematode parasite of ruminants, Haemonchus contortus. Funct Integr Genomics 2010;10:589-601. [DOI: 10.1007/s10142-010-0172-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
48 Wang Y, Li Z, Li W, Liu S, Han B. Methylation of CDX2 gene promoter in the prediction of treatment efficacy in colorectal cancer. Oncol Lett 2018;16:195-8. [PMID: 29928401 DOI: 10.3892/ol.2018.8670] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Takami H, Sentani K, Matsuda M, Oue N, Sakamoto N, Yasui W. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules. Pathobiology 2012;79:154-61. [PMID: 22286119 DOI: 10.1159/000335694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Han JJ, Xie de R, Wang LL, Liu YQ, Wu GF, Sun Q, Chen YX, Wei Y, Huang ZQ, Li HG. Significance of glutathione peroxidase 1 and caudal-related homeodomain transcription factor in human gastric adenocarcinoma. Gastroenterol Res Pract 2013;2013:380193. [PMID: 24228025 DOI: 10.1155/2013/380193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Shiotani A, Kamada T, Yamanaka Y, Manabe N, Kusunoki H, Hata J, Haruma K. Sonic hedgehog and CDX2 expression in the stomach. J Gastroenterol Hepatol. 2008;23 Suppl 2:S161-S166. [PMID: 19120891 DOI: 10.1111/j.1440-1746.2008.05406.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
52 Jang B, Kim WH. Molecular Pathology of Gastric Carcinoma. Pathobiology 2011;78:302-10. [DOI: 10.1159/000321703] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 7.1] [Reference Citation Analysis]
53 Tsukamoto T, Mizoshita T, Tatematsu M. Animal models of stomach carcinogenesis. Toxicol Pathol. 2007;35:636-648. [PMID: 17654405 DOI: 10.1080/01926230701420632] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
54 Ikarashi S, Nishikura K, Ajioka Y, Aoyagi Y. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2. Gastric Cancer. 2013;16:208-219. [PMID: 22829163 DOI: 10.1007/s10120-012-0172-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
55 Lee BH, Kim N, Lee HS, Kang JM, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry. Gut Liver 2012;6:71-7. [PMID: 22375174 DOI: 10.5009/gnl.2012.6.1.71] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
56 Matsuda M, Sentani K, Noguchi T, Hinoi T, Okajima M, Matsusaki K, Sakamoto N, Anami K, Naito Y, Oue N. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis. Pathol Int. 2010;60:673-680. [PMID: 20846265 DOI: 10.1111/j.1440-1827.2010.02587.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
57 Natsagdorj L, Sugihara H, Bamba M, Hattori T. Intratumoural heterogeneity of intestinal expression reflects environmental induction and progression-related loss of induction in undifferentiated-type gastric carcinomas. Histopathology. 2008;53:685-697. [PMID: 19102008 DOI: 10.1111/j.1365-2559.2008.03166.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
58 Kang JM, Lee BH, Kim N, Lee HS, Lee HE, Park JH, Kim JS, Jung HC, Song IS. CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci. 2011;26:647-653. [PMID: 21532856 DOI: 10.3346/jkms.2011.26.5.647] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
59 Debruyne PR, Witek M, Gong L, Birbe R, Chervoneva I, Jin T, Domon-Cell C, Palazzo JP, Freund JN, Li P. Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology. 2006;130:1191-1206. [PMID: 16618413 DOI: 10.1053/j.gastro.2005.12.032] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 4.4] [Reference Citation Analysis]
60 Zhang JF, Zhang JG, Kuai XL, Zhang H, Jiang W, Ding WF, Li ZL, Zhu HJ, Mao ZB. Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2'-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells. Exp Ther Med. 2013;5:735-741. [PMID: 23408490 DOI: 10.3892/etm.2013.901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
61 Solcia E, Klersy C, Vanoli A, Grillo F, Manca R, Tava F, Luinetti O, Fiocca R. The contribution of cell phenotype to the behavior of gastric cancer. Gastric Cancer. 2013;16:462-471. [PMID: 23329390 DOI: 10.1007/s10120-012-0208-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
62 Bai Z, Ye Y, Chen D, Shen D, Xu F, Cui Z, Wang S. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis. APMIS 2007;115:1383-90. [PMID: 18184409 DOI: 10.1111/j.1600-0463.2007.00654.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
63 Tsukamoto T, Toyoda T, Mizoshita T, Tatematsu M. Helicobacter pylori infection and gastric carcinogenesis in rodent models. Semin Immunopathol. 2013;35:177-190. [PMID: 23111700 DOI: 10.1007/s00281-012-0357-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
64 Tanaka H, Tsukamoto T, Mizoshita T, Inada K, Ogasawara N, Cao X, Kato S, Joh T, Tatematsu M. Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach. Virchows Arch 2005;447:806-15. [PMID: 16088401 DOI: 10.1007/s00428-005-0040-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
65 Sentani K, Oue N, Naito Y, Sakamoto N, Anami K, Oo HZ, Uraoka N, Aoyagi K, Sasaki H, Yasui W. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis. Carcinogenesis 2012;33:1081-8. [PMID: 22411957 DOI: 10.1093/carcin/bgs121] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
66 Toki F, Takahashi A, Aihara R, Ogata K, Ando H, Ohno T, Mochiki E, Kuwano H. Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma. World J Gastroenterol 2010; 16(22): 2764-2770 [PMID: 20533596 DOI: 10.3748/wjg.v16.i22.2764] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
67 Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Nishiwaki H, Ebi M, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T. Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement. Gastroenterol Res Pract 2014;2014:687257. [PMID: 24829572 DOI: 10.1155/2014/687257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
68 Wang Y, Li Z, Li W, Liu S, Han B. Methylation of promoter region of CDX2 gene in colorectal cancer. Oncol Lett 2016;12:3229-33. [PMID: 27899987 DOI: 10.3892/ol.2016.5109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
69 Oue N, Sentani K, Sakamoto N, Yasui W. Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype. Cancer Sci. 2015;106:951-958. [PMID: 26033320 DOI: 10.1111/cas.12706] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
70 Okamoto N, Kawachi H, Yoshida T, Kitagaki K, Sekine M, Kojima K, Kawano T, Eishi Y. “Crawling-type” adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma. Gastric Cancer 2013;16:220-32. [DOI: 10.1007/s10120-012-0173-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
71 Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther Symp Series 2006;2:71-80. [DOI: 10.1111/j.1746-6342.2006.00028.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
72 Morita S, Yoshida A, Goto A, Ota S, Tsuta K, Yokozawa K, Asamura H, Nakajima J, Takai D, Mori M, Oka T, Tamaru J, Itoyama S, Furuta K, Fukayama M, Tsuda H. High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol 2013;37:924-32. [PMID: 23629442 DOI: 10.1097/PAS.0b013e31827e1e83] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
73 Mizoshita T, Kataoka H, Kubota E, Okamoto Y, Shimura T, Mori Y, Wada T, Ogasawara N, Sasaki M, Kamiya T, Joh T. Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil. Int J Clin Oncol 2008;13:373-6. [PMID: 18704642 DOI: 10.1007/s10147-007-0750-2] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
74 Sullivan LM, Smolkin ME, Frierson HF Jr, Galgano MT. Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology. Am J Surg Pathol 2008;32:1608-12. [PMID: 18753946 DOI: 10.1097/PAS.0b013e31816d71c4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
75 Jinawath A, Akiyama Y, Yuasa Y, Pairojkul C. Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma. J Cancer Res Clin Oncol. 2006;132:805-810. [PMID: 16794828 DOI: 10.1007/s00432-006-0129-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
76 Hayakawa M, Nishikura K, Ajioka Y, Aoyagi Y, Terai S. Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach. Pathol Int 2017;67:131-40. [PMID: 28088838 DOI: 10.1111/pin.12506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
77 Tsukamoto T, Yokoi T, Maruta S, Kitamura M, Yamamoto T, Ban H, Tatematsu M. Gastric adenocarcinoma with chief cell differentiation. Pathol Int. 2007;57:517-522. [PMID: 17610477 DOI: 10.1111/j.1440-1827.2007.02134.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
78 Ogasawara N, Tsukamoto T, Mizoshita T, Inada K, Cao X, Takenaka Y, Joh T, Tatematsu M. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology. 2006;49:612-621. [PMID: 17163846 DOI: 10.1111/j.1365-2559.2006.02560.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
79 Ara H, Takagishi M, Enomoto A, Asai M, Ushida K, Asai N, Shimoyama Y, Kaibuchi K, Kodera Y, Takahashi M. Role for Daple in non-canonical Wnt signaling during gastric cancer invasion and metastasis. Cancer Sci 2016;107:133-9. [PMID: 26577606 DOI: 10.1111/cas.12848] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
80 Nakayama C, Yamamichi N, Tomida S, Takahashi Y, Kageyama-Yahara N, Sakurai K, Takeuchi C, Inada KI, Shiogama K, Nagae G, Ono S, Tsuji Y, Niimi K, Fujishiro M, Aburatani H, Tsutsumi Y, Koike K. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation. Cancer Sci 2018;109:3853-64. [PMID: 30289576 DOI: 10.1111/cas.13821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
81 Li QL, Yang ZL, Liu JQ, Miao XY. Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome. Pathol Oncol Res 2011;17:561-8. [PMID: 21221877 DOI: 10.1007/s12253-010-9346-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
82 . Retracted article: Interleukin-1beta and tumor necrosis factor-alpha regulation of CDX2 homeobox gene through nuclear factor kappa B-dependent pathway in the intestinal-type gastric cancer. Med Oncol 2010;27:1155. [PMID: 19908169 DOI: 10.1007/s12032-009-9352-3] [Reference Citation Analysis]
83 Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 2006;208:633-42. [DOI: 10.1002/path.1922] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 5.4] [Reference Citation Analysis]
84 Domori K, Nishikura K, Ajioka Y, Aoyagi Y. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis. Gastric Cancer. 2014;17:263-272. [PMID: 23828549 DOI: 10.1007/s10120-013-0281-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
85 Choi BJ, Kim CJ, Cho YG, Song JH, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS. Altered expression of CDX2 in colorectal cancers. APMIS. 2006;114:50-54. [PMID: 16499661 DOI: 10.1111/j.1600-0463.2006.apm_292.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
86 Anderson C, Nijagal A, Kim J. Molecular markers for gastric adenocarcinoma: an update. Mol Diagn Ther 2006;10:345-52. [PMID: 17154651 DOI: 10.1007/BF03256211] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
87 Yuan J, Yin Z, Tao K, Wang G, Gao J. Homeobox protein CDX2 as a prognostic biomarker in solid malignancies: a meta-analysis. Oncotarget 2017;8:89160-72. [PMID: 29179508 DOI: 10.18632/oncotarget.20808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
88 Liu Q, Teh M, Ito K, Shah N, Ito Y, Yeoh KG. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Mod Pathol. 2007;20:1286-1297. [PMID: 17906616 DOI: 10.1038/modpathol.3800968] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
89 Katano T, Mizoshita T, Tsukamoto H, Nishie H, Inagaki Y, Hayashi N, Nomura S, Ozeki K, Okamoto Y, Shimura T, Mori Y, Kubota E, Tanida S, Kataoka H, Kuno T, Takahashi S, Joh T. Ectopic Gastric and Intestinal Phenotypes, Neuroendocrine Cell Differentiation, and SOX2 Expression Correlated With Early Tumor Progression in Colorectal Laterally Spreading Tumors. Clin Colorectal Cancer 2017;16:141-6. [PMID: 27816419 DOI: 10.1016/j.clcc.2016.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Kato S, Matsukura N, Tsukada K, Matsuda N, Mizoshita T, Tsukamoto T, Tatematsu M, Sugisaki Y, Naito Z, Tajiri T. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790-794. [PMID: 17470129 DOI: 10.1111/j.1349-7006.2007.00478.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
91 Jun SY, Eom DW, Park H, Bae YK, Jang KT, Yu E, Hong SM. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. Mod Pathol 2014;27:1364-74. [PMID: 24603585 DOI: 10.1038/modpathol.2014.36] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
92 Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology. 2005;46:649-658. [PMID: 15910596 DOI: 10.1111/j.1365-2559.2005.02170.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.5] [Reference Citation Analysis]
93 Hansel DE, Maitra A, Lin JW, Goggins M, Argani P, Yeo CJ, Piantadosi S, Leach SD, Biankin AV. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. J Clin Oncol. 2005;23:1811-1818. [PMID: 15774774 DOI: 10.1200/jco.2005.03.068] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
94 Chang YT, Hsu C, Jeng YM, Chang MC, Wei SC, Wong JM. Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma. J Gastroenterol Hepatol. 2007;22:389-394. [PMID: 17295772 DOI: 10.1111/j.1440-1746.2006.04487.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]